Reductive Surgery Plus Percutaneous Isolated Hepatic Perfusion for Multiple Advanced Hepatocellular Carcinoma

Annals of Surgery

Volumn 239, Issue 1, 2004, Pages 53-60

  Ku, Yonson ^a   Iwasaki, Takeshi ^a   Tominaga, Masahiro ^a   Fukumoto, Takumi ^a   Takahashi, Tetsuya ^a   Kido, Masahiro ^a   Ogata, Satoshi ^a   Takahashi, Masanori ^a   Kuroda, Yoshikazu ^a   Matsumoto, Shinichi ^a   Obara, Hidefumi ^a  

^a KOBE UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CONTROL; CANCER MORTALITY; CANCER PATIENT; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CATHETER ABLATION; CAUSE OF DEATH; CLINICAL ARTICLE; FEMALE; HUMAN; LIVER CARCINOMA; LIVER FUNCTION; LIVER PERFUSION; LIVER RESECTION; MALE; PERCUTANEOUS ISOLATED HEPATIC PERFUSION; PRIORITY JOURNAL; SURVIVAL RATE;

ADULT; BIOPSY, NEEDLE; CARCINOMA, HEPATOCELLULAR; CHEMOTHERAPY, ADJUVANT; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; COMBINED MODALITY THERAPY; DOXORUBICIN; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROBABILITY; PROSPECTIVE STUDIES; RISK ASSESSMENT; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 10744222925     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.sla.0000103133.03688.3d     Document Type: Article

References (26)

1. Mor E, Tur Kaspa R, Sheiner P, et al. Treatment of hepatocellular carcinoma associated with cirrhosis in the era of liver transplantation. Ann Intern Med. 1998;129:643-653.
2. Bismuth H, Houssin D, Ornowski J, et al. Liver resections in cirrhotic patients: a Western experience. World J Surg. 1986;10:311-317.
3. Liver Cancer Study Group of Japan. Primary liver cancer in Japan: clinicopathologic features and results of surgical treatment. Ann Surg. 1990;211:277-284.
4. Belghiti J, Panis Y, Farges O, et al. Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis. Ann Surg. 1991;214:114-117.
5. Sasaki Y, Imaoka S, Masutani S, et al. Influence of coexisting cirrhosis on long-term prognosis after surgery in patients with hepatocellular carcinoma. Surgery. 1992;112:515-512.
6. Nagasue N, Uchida M, Makino Y, et al. Incidence and factors associated with intrahepatic recurrence following resection of hepatocellular carcinoma. Gastroenterology. 1993;105:488-494.
7. Livraghi T, Bolondi L, Lazzaroni S, et al. Percutaneous ethanol injection in the treatment of hepatocellular carcinoma in cirrhosis. A study on 207 patients. Cancer. 1992;69:925-929.
8. Vilana R, Bruix J, Bru C, et al. Tumor size determines the efficacy of percutaneous ethanol injection for the treatment of small hepatocellular carcinoma. Hepatology. 1992;16:353-357.
9. Livraghi T, Giorgio A, Mariu G, et al. Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection. Radiology. 1995;197:101-108.
10. Hasegawa S, Yamasaki N, Hiwaki T, et al. Factors that predict intrahepatic recurrence of hepatocellular carcinoma in 81 patients initially treated by percutaneous ethanol injection. Cancer. 1999;86:1682-1690.
11. Lin DY, Lin SM, Liaw YF. Non-surgical treatment of hepatocellular carcinoma. J Gastroenterol Hepatol. 1997;12:S319-S328.
12. Hamazoe R, Hiraoka Y, Ohtani S, et al. Intraoperative microwave tissue coagulation as treatment for patients with nonresectable hepatocellular carcinoma. Cancer. 1994;75:794-800.
13. Jiao LR, Hansen DD, Havilik R, et al. Clinical short-term results of radiofrequency ablation in primary and secondary liver tumors. Am J Surg. 1999;177:33-306.
14. Curley SA, Izzo F, Delrio P, et al. Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies. Ann Surg. 1999;230:1-8.
15. Curley SA, Izzo F, Ellis LM, et al. Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis. Ann Surg. 2000;232:381-391.
16. Ku Y, Saitoh M, Nishiyama H, et al. Extracorporeal removal of anti-cancer drugs in hepatic arterial infusion: the effect of direct hemoperfusion combined with venovenous bypass. Surgery. 1990;107:273-281.
17. Ku Y, Fukumoto T, Iwasaki T, et al. Clinical pilot study on high-dose intraarterial chemotherapy with direct hemoperfusion under hepatic venous isolation in patients with advanced hepatocellular carcinoma. Surgery. 1995;117:510-519.
18. Ku Y, Fukumoto T, Maeda I, et al. Single catheter technique of hepatic venous isolation and extracorporeal charcoal hernoperfusion for malignant liver tumors. Am J Surg. 1997;173:103-109.
19. Ku Y, Iwasaki T, Fukumoto T, et al. Induction of long-term remission in advanced hepatocellular carcinoma with percutaneous isolated liver chemoperfusion. Ann Surg. 1998;227:519-526.
20. Ravikumar TS, Pizzorno G, Bodden W, et al. Percutaneous hepatic vein isolation and high-dose hepatic arterial infusion chemotherapy for unresectable liver tumors. J Clin Oncol. 1994;12:2723-2736.
21. Miller AB, Hoogstraten B, Staquet M, et al. Reporting results of cancer treatment. Cancer. 1981;47:207-214.
22. Division of Cancer Treatment. Guidelines for the Reporting of Adverse Drug Reactions. Bethesda, MD: National Care Institute; 1988.
23. Ku Y, Tominaga M, Iwasaki T, et al. Long-term results of percutaneous isolated hepatic perfusion for advanced hepatocellular carcinoma. Kan-Tan-Sui. 1999;39:869-876.
24. Yamamoto M, Iizuka H, Matsuda M, et al. The indications for tumor mass reduction surgery and subsequent multidisciplinary treatments in stage IV hepatocellular carcinoma. Surgery Today Jpn J Surg. 1993;23:675-681.
25. Ikai I, Yamaoka Y, Yamamoto Y, et al. Surgical intervention for patients with stage IVA hepatocellular carcinoma without lymph node metastasis. Ann Surg. 1998;227:433-439.
26. Shimada M, Takenaka K, Kawahara N, et al. Surgical treatment strategy for patients with stage IV hepatocellular carcinoma. Surgery. 1996;119:517-522.